Search
Close this search box.

GCP-Service International, receives the CIR (French Research Tax Credit) accreditation

An accreditation by the French Ministry of Higher Education and Research

We are delighted to announce that GCP-Service International, a leading provider of clinical research services, is also officially recognized by the French Ministry of Higher Education and Research as a private enterprise engaged in research activities thereby in possession of the research tax credit or CIR.

This accreditation, as outlined in article 244  quater B of the French General Tax Code (CGI), serves as a vital tax incentive for our French clients/companies actively involved in research and development. The accreditation not only reflects our continued pursuit of making clinical trials accessible, but also enables us to enhance our support to our valued French clients in their pursuit of pioneering medical discoveries.

As a renowned leader in the industry, GCP-Service International has a proven track record of providing top-tier clinical research services, ensuring that each study adheres to the highest standards of quality, safety, and compliance. This accreditation further solidifies our position as a trusted partner for pharmaceutical, biotechnology, and medical device companies seeking reliable and efficient clinical research solutions.

With the CIR accreditation now in place, our clients can not only benefit from our exceptional expertise but also gain financial advantages that drive continued growth and progress in the healthcare sector.

The accreditation is valid now and will give our clients an opportunity to gain significant reductions on their tax bills, while advancing innovative research initiatives, further fostering the growth of cutting-edge clinical investigations.

The French Ministry of Higher Education and Research through this incentive, sets the stage for an even brighter future in clinical research, in the EU. We remain committed to such schemes, making a meaningful impact on the industry and look forward to collaborating with our clients to achieve groundbreaking advancements in medical knowledge and patient care.

To take advantage of our unique expertise and benefit from the tax incentive, contact us today.

More To Explore